Discussions & Speaker Bios

Below is the event schedule for Techna 2013: Technology For Personalized Cancer Medicine. Here you can view the speaker bios as well as video recordings of some of the panels.  You can click on an event time or a speaker name to view the detailed information for each. The Techna 2013 Symposium featured a live tweeting system for participants to add comments in parallel to the discussions and presentations.


8:00-8:45

Breakfast and Registration

8:45-9:00

Opening Remarks
Robert Bell
CEO, University Health Network

9:00-9:45

PCM: The definition, the opportunity, and the therapeutic trajectory
Moderated by: Robert Bell
CEO and President, University Health Network
Fei-Fei Liu
Director, Radiation Medicine Program, Princess Margaret Cancer Centre, UHN
Jonathan Irish
Chief, Surgical Oncology, Princess Margaret Cancer Centre, UHN; Co-lead, Guided Therapeutics, Techna Institute, UHN
Lillian Siu
Medical Oncologist, Princess Margaret Cancer Centre, UHN
Session I: Case Study

9:45-10:05

The Health Policy Challenges of PCM
Timothy Caulfield
Professor, Faculty of Law and School of Public Health, University of Alberta

10:05-10:20

Break

10:20-11:10

Signal Generation: Advances to interrogate tumor
Moderated by: Christine Allen
Associate Professor, University of Toronto
Jianghong Rao
Associate Professor, Stanford University
Fiona Ginty
Principal Scientist, GE
Shana Kelley
Professor, University of Toronto
Session III: Questions & Answers

11:10-12:15

Informatics, communications, computation, and clinical tools for PCM
Moderated by: Brenda Gallie
Senior Scientist, Ontario Cancer Institute, UHN
Igor Jurisica
Senior Scientist, Ontario Cancer Institute; Co-lead, Informatics and Communications Technology, Techna Institute, UHN
Ted Chang
CTO, Quanta Computer
Martin S. Kohn
Chief Medical Scientist, IBM Research
Prateek Dwivedi
Cancer Informatics, Techna Institute, UHN
Session IV: Questions & Answers

12:15-13:15

Lunch and Expo

13:15-14:05

Acting on Signals: Guided therapeutics and personalized treatment plans; multi-modal therapeutics; targeted drug therapies and standardization
Moderated by: Paul Alofs
President & CEO, Princess Margaret Cancer Foundation, UHN
Gary Palmer
Senior Vice President, Medical Affairs, Foundation Medicine
Gang Zheng
Senior Scientist, Ontario Cancer Institute; Co-lead, Nanotechnology & Radiochemistry, Techna Institute, UHN
Ulrik B. Nielsen
Senior Vice President and Chief Scientific Officer, Merrimack Pharmaceuticals
Session V: Questions & Answers

14:05-14:15

Break

14:15-15:00

Innovation Debate: Can we execute personalized cancer medicine?
Moderated by: Michael Julius
VP Research, Sunnybrook Health Sciences Centre
Nicole Mittmann
Executive Director, Health Outcomes and Pharmacoeconomic Centre, Sunnybrook Health Sciences Centre
Jeffrey Hoch
Research Scientist, Centre for Research on Inner City Health, St. Michael’s Hospital

15:00-15:15

Post-Debate Commentary
Tom Ehrlich
President and Managing Partner, Tanurb Developments Inc.
Bill Mantel
Assistant Deputy Minister
Research, Commercialization and Entrepreneurship Division
Ministry of Research & Innovation / Ministry of Economic Development, Trade & Employment
Robert Bell
CEO, University Health Network

15:15-15:30

Closing Remarks
Dr. David Jaffray
Director, Techna Institute, UHN